general level of prices, profits and the rate of competitive innovation throughout the industry are intimately linked.
To summarize, prices set at levels reflecting the value of any new product to the user are the key to the rate of industrial innovation. The surplus net cash flow represents the major source of funds for a continuous and expanding research and development programme. The risks of obsolescence through the actions of competitors in developing similar or more effective second generation products is the stimulus to a continuation and expansion of this investment. A firm's competitors following a similar strategy are all equally vulnerable and affected by the actions of the initial innovating firm. Through the treadmill of product competition, given a pricing strategy which not merely seeks to recoup or absorb past costs, but reflects the value of the product to the user, a self-generating process of industrial innovation and development can be stimulated. Medicine and the Challenge of Technology I have chosen to treat the subject of medicine and the challenge of technology initially from a philosophical point of view. The challenges appear to me to fall under six major headings.
First, we have the challenge to our sense of proportion. The fact that something becomes techno'61gically possible does not mean that it is necessarily desirable, and we must somehow or other learn to pick and choose how and where to apply technology, whether in pathology or in medicine in general.
Secondly, we face the challenge to our humanity. Even if the application of technology results in some operation being performed more efficiently, or more cheaply, it is bad technology if it leads to a major distortion of human motivation or the way in which people like to be treated. Technology should not run us, we should use it for our benefit. This means that the good designer and the good administrator must not be satisfied merely by a machine which works, but only by one which is also correctly matched into its human environment.
The third challenge is to our educational system. There is no point in having a population which contains individuals capable of designing clever machines if facilities are not provided at the same time to train people to operate them, to look after them and to understand them. If, as is almost always the case, the new machines also provide data about a patient which have not previously been available, then the decision makers, be they doctors, nulses or pathologists, must understand the significance of the information; otherwise the effect may be confusing rather than beneficial.
The fourth challenge is to our business acumen. Instrument development is costly and is only justified if the market develops. What technology may be able to achieve often anticipates the expressed wishes of the 'customer'. The wise manufacturer in my opinion not only fulfils recognized market requirements but spends some of his energies quite ethically in creating the market for the next generation of equipment. Conversely, the minority desire must be recognized as such, and the manufacturer must harden his heart and not spend his precious risk capital and resources acting on the advice of the enthusiastic but isolated individual.
Fifthly, there is the challenge to academic research organizations. I do not want to add to the endless argument about the relative merits of pure and applied research. However, in a situation where money and other resources are scarce, the decision to pursue a particular line of research to the exclusion of another is very akin to an investment decision in the realm of business. The advantage of the business man is that the success or failure of his decisions can be measured by the profitability of his organization. No such unequivocal scale exists to measure the 'profit' of research work. Nevertheless, I believe that there is room in the organization of research work for some management strategy, that people can be trained in management technique without damaging their scientific integrity, and that this would benefit the conduct of research work and its exploitation.
Lastly, we face the challenge of how we actually manage society. All of us would probably be prepared to admit grudgingly that, taking the longer view, there is no real limit to what technology can achieve, provided enough effort and investment is channelled into a particular area. How do we then arrange our priorities and make our decisions when these give us the power of life or death over an individual? How do we balance the claims of an individual who may be kept alive by enough investment against the claims of a group who may merely be made happier, more productive or less uncomfortable? We have no explicit mechanism for making such decisions and at present hide behind artificial shortages of equipment or facilities which only postpone the day when the crunch comes.
I shall now try to deal in slightly greater detail with each of these six challenges.
Our Sense ofProportion It seems to me that people of sufficiently high motivation, say in a good teaching hospital, can probably give a patient excellent care with the minimum of technology. I regard technology essentially as the great leveller, which makes it possible for less skilled, less highly motivated, less clever people, to give as good a service to the mass of the population as the minority would receive without technology by employing very clever and highly motivated people in special institutions. It is almost a decision of principle whether one supports the 'great leveller' type of technology or whether one fixes one's attention on the newsworthy item, the artificial heart or the complex treatment whose contribution to the nation's health is trivial.
It is unfortunate that our own prestige structure is organized in such a way (and this is true of most highly developed countries) that there is a tendency to focus more and more research and more and more manpower on fewer and fewer people. It is the great surgical team of 20 surgeons doing something very exciting which attracts the prestige, and not the application of possibly very much more humble technology to a greater mass of people. Does Technology Dehumanize the Practice ofMedicine ? I think that it is often possible to demonstrate that there is an apparent decrease in cost consequent on a high degree of centralization of a particular procedure. However, the arithmetic may not always take all factors into account. It is an understandable tendency of Ministries to organize their affairs in such a way as to minimize the cost of their own operations without direct reference to the overall cost to the nation.
I am particularly interested in the distribution of diagnostic facilities between hospitals and general practitioners. It is probably possible to provide certain diagnostic services peripherally either in the surgery or the health centre which would make minimum demands on the skill or interpretive ability of the general practitioner. These would save the patient a visit to the hospital, and perhaps a second visit to the doctor, quite apart from the advantages of continuity of treatment and job satisfaction for the doctor. However, there is, as far as I know, no inter-Ministry costing mechanism by which extra investment by the Ministry of Health can be recouped by the gain of less working time lost by the patient and less insurance payments.
There is an interesting difference in design concepts between centralized and distributed technological aids. You can either make a large piece of machinery, like a high-speed automatic analyser which substitutes for the skill and manipulative ability of a large number of people, screw it down in one place and bring all your samples to it. Or, as an alternative, you can use perhaps an even bigger and more complicated machine and make it bottle skill in little packages which can be distributed widely and from which the skill, like the genie from a bottle, can be released anywhere at will. The best example of this approach is the Polaroid photographic process in which, largely by clever packaging, a skilled laboratory (dark-room) procedure can be performed anywhere at any time by unskilled individuals.
Might not this philosophy be applied to chemical and biological tests?
This seems to be an example of two totally different approaches to the problem of bringing the fruits of technology to bear on certain types of medical investigation. Personally, without decrying in any way the need for large centralized services to serve hospitals, I believe that there is an equal need for having this packaged skill available much nearer the periphery. This would preserve the right sort of human motivation and job satisfaction, which can only be obtained by making the information available at the time and place where it is required.
The Challenge to our Educational System I think it is wrong, and it is bad technology, if the introduction of machinery requires people to be 'better' than the people who were employed before. The reason for putting automation or putting machinery into industry has generally been to replace the craftsman. For a craftsman to make a plastic ashtray by hand carving would be quite difficult. Even the machine which makes plastic ashtrays by the million does not require anyone as skilled as the craftsman for its operation. It is unfortunate that a great deal of the instrumentation which is being introduced into medicine at the moment requires more rather than less skill from the people who are required to operate it. This seems to run counter to my first proposition that technology should be the great leveller.
Machinery must therefore be designed which does not make these extra demands. This nmay well mean that instruments have to be more sophisticated, so as to eliminate the need for adjustment. They may have to have means to indicate that they are not working correctly and should, as far as possible, be capable of being repaired by their actual users. This may sound a very tall order, but I am convinced that whilst particularly the last requirement may not be important in a colorimeter or an automatic analyser, it is vital in intensive care monitoring equipment which has to be functional twenty-four hours a day, seven days a week.
The merit of an approach of 'service without the serviceman' is twofold. First, any commercial organization will find it difficult to provide sufficiently rapid service at an economic level for equipment which is used twenty-four hours a day. Extra investment in spare equipment would be a partial answer. Secondly, and of much greater importance, is the change of attitude which would occur towards the machinery if the actual users felt that they were in full control. An ordinary drip set is a highly unreliable devicethe drip rate changes, the needle blocks, the bottle is emptybut because the nurse knows exactly what to do to put it right the failure hardly registers and her faith in the device is unimpaired. A fault in an electronic piece of equipment which in principle may be no more serious means that she has to ask for outside help. The failure does register and very soon her faith in the instrument is shaken. But even if the instrument does not technically fail, it may still be misused or misunderstood. I am convinced that one of the reasons why the introduction of some kinds of equipment into hospitals is making such relatively slow progress is that the level of technical culture of the hospital society is simply not ready to receive it. This is no one's fault, and is paralleled by a similar reluctance to adopt new techniques in industry, but it does mean that education has failed to keep pace with technical advance. Two steps should be taken to close the gap. First, as has already been stated, machinery can be made less demanding and should by inclusion of diagnostic features and modular design enable the user to deal with the majority of confidencesapping faults. Secondly, we must find ways of educating people in technological appreciation, so that they may develop a feeling for instrumentation, without necessarily turning them into technicians or technologists.
The Challenge to Business Acumen How should the business man find out what to make? He must, of course, do market research and ask the advice of the appropriate financing authorities and perform further development on his existing product range. But is this all he should do? And is this a policy which might carry him to the forefront of his particular section of industry? I do not think that it is; in addition he should explore applications of technology which utilize the most recent advances and which are ahead of the existing market. Only if this is done will it be possible to reduce the ever widening gap between what is feasible and what is actually applied. The commercial risks may well be too great for the manufacturer to carry by himself, and it is here that tripartite collaboration between the academic or government research laboratory, the manufacturer and public sources of finance (Ministry or National Research Development Corporation) can be most fruitful.
I have called this leapfrogging of expressed market desires 'prospective technology'. It is based on the belief that conventional market research is generally able neither to elicit a desire for something which is really new nor to gauge the acceptance of a notional device which is outside present practice. The reason for this is that there are few people who can in their imagination really extrapolate very far outside their everyday experience. The research laboratory might contain such people. If they play their part correctly, they can act as catalysts to help the manufacturer bridge the gap between an exciting idea and a product which might not only represent a step forward in applied technology but could also give him a temporary market monopoly.
For this to come about the research worker may have to collaborate with the manufacturer to an extent which is unusual in this country, and which should not stop short at the communication of technical data, but might well include help to get the product launched. The reason that help with launching is important is that, according to the belief expressed above, people who can really see the full potential of the idea will be in short supply and there will be a period when only the inventors or designers can really see the full extent of the promised land.
A Pleafor the Unexciting Development Finally, I should like to make a brief reference to the ethical questions raised by our increasing ability to improve medical care by technological investment. I am not qualified to say anything about the solution to the problem of how much investment in money and resources a single life is worth. What I would like to do is to make a plea not to neglect the humble and unexciting application of technology which could serve to make the chronically ill more comfortable, allow the old and partially disabled to remain independent in their own homes for longer, and improve basic hospital treatment everywhere. I would hate to belong to a profession which helped to perform technical miracles for the few but did little for the many.
